BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 2019
View Archived Issues
beta-1,4-GalT-V as a novel diagnostic and therapeutic biomarker in human CRC
Read More
Healthy people with afflicted parents give insight into AD genetics
Read More
Autologous exosomes deliver chemotherapy
Read More
E. coli toxin produced in unexpected ways
Read More
Enrollment ongoing in first-in-human study of PBF-1650
Read More
Brown University and Bryant University describe new antibacterials
Read More
Meiji Seika Pharma, Kaken Pharmaceutical patent nuclear receptor RORgamma antagonists
Read More
Mirati Therapeutics initiates phase I/II study of MRTX-849
Read More
2-Acylglycerol O-acyltransferase 2 inhibitors identified at Shionogi
Read More
Phase II trial of varlitinib in advanced gastric cancer does not meet primary endpoint
Read More
Novartis presents lysine-specific histone demethylase 1A inhibitors
Read More
New multitargeted PARP, PI3K and/or BRD4 inhibitors disclosed by SignalRx Pharmaceuticals
Read More
Hampton University, the University of Virginia describe labeled thymidine compounds
Read More
Verona reports topline data from 3-day phase II study of ensifentrine for COPD
Read More
Alnylam explores ALN-AAT02 in phase I/II study for ZZ type AAT deficiency liver disease
Read More
Researchers elucidate link between miR-377 and atherosclerosis
Read More
New Kv7 potassium channel openers show promise for epilepsy
Read More
EpicentRx begins phase III trial of RRx-001 prior to platinum doublet in small cell carcinoma
Read More
Bioverativ begins phase I/II study of BIVV-003 in sickle cell disease
Read More
New study to investigate DKN-01 in DKK1-positive metastatic castration-resistant prostate cancer
Read More
